Gene · 4016
Papers1,658
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,658
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Epigenetics of glaucoma in the trabecular meshwork. | Clin Epigenetics | 2025 | 41422257 | PubTator, text mining | PubMed |
| A fibroblast-specific gene signature as a therapeutic target for glioblastoma developed based on the characteristics of tumor microenvironment. | Eur J Med Res | 2025 | 41310846 | PubTator, text mining | PubMed |
| Scientometric analysis of extracellular vesicles in vision science (up to 2024). | J Nanobiotechnology | 2025 | 41074034 | PubTator, text mining | PubMed |
| Multi-omic underpinnings of heterogeneous aging across multiple organ systems. | Cell Genom | 2025 | 41043431 | PubTator, text mining | PubMed |
| Extracellular matrix alterations in chronic ischemic cardiomyopathy revealed by quantitative proteomics. | JCI Insight | 2025 | 41026521 | PubTator, text mining | PubMed |
| Identifying survival subtypes with autoencoder using multiple types of high-dimensional genomic data from studies of glioblastoma multiforme. | Brief Bioinform | 2025 | 41016009 | PubTator, text mining | PubMed |
| Metabolomic Signatures and Predictive Utility of LOXL1-Associated Genetic Risk Scores for Exfoliation Syndrome/Glaucoma in US Cohorts. | Metabolites | 2025 | 41002966 | PubTator, text mining | PubMed |
| Establishment of an Advanced In Vitro Model for Pseudoexfoliation Syndrome and Glaucoma. | Invest Ophthalmol Vis Sci | 2025 | 40996277 | PubTator, text mining | PubMed |
| E2-regulated transcriptome complexity revealed by long-read direct RNA sequencing: from isoform discovery to truncated proteins. | RNA Biol | 2025 | 40965441 | PubTator, text mining | PubMed |
| Enhancer-targeting CRISPR screens at coronary artery disease loci suggest shared mechanisms of disease risk. | medRxiv | 2025 | 40950476 | PubTator, text mining | PubMed |
| [Stiffness of scleral fibroblasts and extracellular matrix remodeling in models of cellular senescence]. | Zhonghua Yan Ke Za Zhi | 2025 | 40921657 | PubTator, text mining | PubMed |
| B3GALT6 mutations lead to compromised connective tissue biomechanics in Ehlers-Danlos syndrome. | JCI Insight | 2025 | 40857410 | PubTator, text mining | PubMed |
| Multiple golgins are required to support extracellular matrix secretion, modification, and assembly. | J Cell Biol | 2025 | 40824304 | PubTator, text mining | PubMed |
| NADPH oxidase 1/4 dual inhibition impairs transforming growth factor-beta protumorigenic effects in cholangiocarcinoma cancer-associated fibroblasts. | Signal Transduct Target Ther | 2025 | 40820091 | PubTator, text mining | PubMed |
| Long noncoding RNA Loxl1-As1 promotes cell apoptosis and suppresses cell proliferation in hepatocellular carcinoma in vitro. | Ann Med Surg (Lond) | 2025 | 40787575 | PubTator, text mining | PubMed |
| Insights into the molecular mechanisms underlying the function of lysyl oxidase like 1 in cancers. | PeerJ | 2025 | 40786111 | PubTator, text mining | PubMed |
| Antigen-presenting CAFs orchestrate immunosuppressive niches via CXCL13-mediated immune cell infiltration dysregulation and prognostic stratification in triple-negative breast cancer. | Int Immunopharmacol | 2025 | 40633212 | PubTator, text mining | PubMed |
| Interferon Regulatory Factor 4 Recruits Immature B Cells to Signal Tertiary Lymphoid Structure Immaturity and Progression of Clear Cell Renal Cell Carcinoma. | Int J Biol Sci | 2025 | 40607252 | PubTator, text mining | PubMed |
| The m5C reader Alyref regulates cardiac remodeling post-myocardial infarction by modulating extracellular matrix protein synthesis in cardiac fibroblasts. | Biochim Biophys Acta Mol Cell Res | 2025 | 40562236 | PubTator, text mining | PubMed |
| Advances in Small Molecule Inhibitors Targeting the Bacterial Lipoprotein Transport System (Lol) in Gram-Negative Bacteria. | Chem Asian J | 2025 | 40536045 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4016/papers?page=3